Goodwin Procter LLP advised Quanta Dialysis Technologies on the deal, while Latham & Watkins advised Novo Holdings. Quanta Dialysis Technologies announced its completion of a $245 million...
This content is for Standard 1 Year members only. LoginJoin Now